Atlas Trials

Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients

Clinical trial NCT01767493 · COMPLETED

Trial details

NCT number
NCT01767493
Sponsor
Institute for Neurodegenerative Disorders
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2012-11-01
Primary completion
2013-11-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.